Gefitinib for Epidermal Growth Factor Receptor Activated Osteoarthritis Subpopulation Treatment

Gefitinib for Epidermal Growth Factor Receptor Activated Osteoarthritis Subpopulation Treatment

Osteoarthritis (OA) is a leading cause of physical disability among aging populations, with no available drugs able to efficiently restore the balance between cartilage matrix synthesis and degradation. Also, OA has not been accurately classified into subpopulations, hindering the development toward...

Full description

Bibliographic Details
Main Authors: Heng Sun, Yan Wu, Zongyou Pan, Dongsheng Yu, Pengfei Chen, Xiaoan Zhang, Haoyu Wu, Xiaolei Zhang, Chengrui An, Yishan Chen, Tian Qin, Xiaoyue Lei, Chunhui Yuan, Shufang Zhang, Weiguo Zou, Hongwei Ouyang
Format: Article
Language:English
Published: Elsevier 2018-06-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396418302044

Internet

http://www.sciencedirect.com/science/article/pii/S2352396418302044

Similar Items